Therorna
Beijing, CN · 5 known investors
Find your way into Therorna
Therorna develops circular RNA-based therapeutic candidates and preventive medicines for diseases with unmet clinical needs. The company was founded in 2021 by domestic experts and overseas-educated PhDs to advance circular RNA technology in drug discovery and therapy.
Investors · 5
Funding
SEC filings, press & company announcements$42M disclosed across 1 round · 2022
- $42MSeries AJun 2022 · 3 sources
MSA Capital (lead), 3H Health Investment, Cenova Capital, Quan Capital, Sherpa Healthcare Partners
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Therorna do?
- Therorna develops circular RNA-based therapeutic candidates and preventive medicines for diseases with unmet clinical needs. The company was founded in 2021 by domestic experts and overseas-educated PhDs to advance circular RNA technology in drug discovery and therapy.
- Who are Therorna's investors?
- Therorna's investors include Cenova Capital, Quan Capital, 3H Health Investment, MSA Capital, Sherpa Healthcare Partners.
- How much funding has Therorna raised?
- Therorna has disclosed $42M raised across 1 round.
- Where is Therorna headquartered?
- Therorna is headquartered in Beijing, CN.